Post Marketing Safety Surveillance of Baricitinib in Three European Registries (I4V-MC-B012)

17/12/2018
31/07/2024
EU PAS number:
EUPAS25142
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

B012 PASS Version 1.0 Nov2018_Redacted

English (604.46 KB - PDF) View document
Study results
Study report
Study report

LY3009104 B012 NI PASS Final Study Report_ENCePP_Redacted.pdf

English (4.31 MB - PDF) View document
Other information